Why Is CytomX (CTMX) Stock Up 180% Today?

CytomX (NASDAQ:CTMX) stock is rocketing higher on Wednesday after the company provided investors with an update for its upcoming earnings report.The oncology-focused biopharmaceutical company told traders that it will release its earnings report for the first quarter of 2024 when markets close on May 8, 2024. It will also host a conference call that same day starting at 5:00 p.m. Eastern Time.Investors will want to keep an eye on EPS and revenue as two important metrics in this earnings report. Wall Street ...